Experts make case for early testing, prevention and care In this report, VINCENT KURAUN explores the groundbreaking ...

Scientists in the US have performed the first personalised gene therapy on a child with a life-threatening rare disease, ...

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing ...

A team of doctors and scientists have successfully treated a rare genetic condition with the first-ever personalized ...

Health camp certifies 35 sickle cell patients for disability benefits, emphasizing prevention, early detection, and community support.

Editas Medicine reports successful gene editing levels in stem cells, supporting potential treatment for sickle cell disease and beta thalassemia. Editas Medicine announced promising new data on ...

In June, the Centers for Medicare & Medicaid Services (CMS) will name the participating states for the agency’s new Cell and ...

Crispr, which acts like genetic scissors to alter genetic code, is already being used for diseases such as sickle cell disease and beta thalassemia which affect hundreds of thousands of people.

Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial ...